the failure to induce enhancement was not due to inefficient antigen binding in vivo , because monoclonal antibodies were as effective as conventional b10.d2 anti-b10.a serum in the induction of acute antibody-mediated graft rejection , and in the opsonization of 51cr-labeled b10.a leukocytes injected into b10.d2 recipients pretreated with antibody .
C1148575
antigen binding
C0003241
antibody